Valuation: Strides Pharma Science Limited

Market Cap 9.91TCr 102.88Cr 90Cr 83Cr 76Cr 144.14Cr 147.34Cr 991.64Cr 390.03Cr 4.85TCr 386.37Cr 377.89Cr 17TCr P/E 2026
15.5x
P/E 2027 * 15.8x
Enterprise Value 9.91TCr 102.88Cr 90Cr 83Cr 76Cr 144.14Cr 147.34Cr 991.64Cr 390.03Cr 4.85TCr 386.37Cr 377.89Cr 17TCr EV / Sales 2026
1.78x
EV / Sales 2027 * 1.7x
Free-Float
68.07%
Yield 2026
0.53%
Yield 2027 * 0.28%
1 day+2.57%
1 week-0.36%
Current month-1.40%
1 month-2.99%
3 months+7.71%
6 months+19.68%
Current year+19.45%
1 week 1,008.5
Extreme 1008.5
1,100
1 month 1,008.5
Extreme 1008.5
1,149.4
Current year 769.6
Extreme 769.6
1,231.45
1 year 769.6
Extreme 769.6
1,231.45
3 years 412.45
Extreme 412.45
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member 82 18/05/2017
Director/Board Member 58 11/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-0.36% - - 102.88Cr
-0.90%-0.15%+14.11%+81.10% 4.82TCr
-0.23%-1.65%+67.15%+112.03% 3.56TCr
-0.76%-1.44%-4.29%+37.63% 1.19TCr
-0.88%-0.62%+17.31%+89.97% 1.18TCr
+0.19%+2.87%+34.92%+139.73% 930.92Cr
+3.37%-0.10%+51.64%-3.75% 701.98Cr
-0.75%-0.91%+17.45%+37.70% 690.82Cr
-2.25%-2.08%+0.45%+209.99% 655.09Cr
-9.93%+0.35%-31.51%+16.58% 612.82Cr
Average -0.96%+0.06%+18.58%+80.11% 1.59TCr
Weighted average by Cap. -0.86%-0.42%+26.79%+86.59%

Financials

2026 2027 *
Net sales 4.83TCr 50Cr 44Cr 40Cr 37Cr 70Cr 72Cr 483.24Cr 190.07Cr 2.36TCr 188.28Cr 184.15Cr 8.14TCr 5.82TCr 60Cr 53Cr 49Cr 45Cr 85Cr 87Cr 582.81Cr 229.23Cr 2.85TCr 227.08Cr 222.1Cr 9.82TCr
Net income 573.7Cr 5.96Cr 5.21Cr 4.8Cr 4.43Cr 8.35Cr 8.53Cr 57Cr 23Cr 280.98Cr 22Cr 22Cr 967.25Cr 627.73Cr 6.52Cr 5.7Cr 5.26Cr 4.85Cr 9.13Cr 9.34Cr 63Cr 25Cr 307.44Cr 24Cr 24Cr 1.06TCr
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,301
Date Price Change Volume
17/26/17 ₹1,077.90 +2.57% 14,873
16/26/16 ₹1,050.90 -1.07% 4,883
15/26/15 ₹1,062.30 -0.67% 2,890
14/26/14 ₹1,069.50 -0.50% 5,430
13/26/13 ₹1,074.85 -0.64% 3,534
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,074.90INR
Average target price
1,338.67INR
Spread / Average Target
+24.54%

Quarterly revenue - Rate of surprise